Pharmafile Logo

Solving your biggest patient recruitment and retention challenges

- PMLiVE

Clinical trial patient recruitment and retention remains one of the key challenges to successfully bringing a new therapeutic to market. An estimated 85% of clinical trials face delays due to enrollment issues [1,2], and poor recruitment is a common reason for discontinuation [3]. Of those successfully enrolled, around 30% are likely to drop out [4], which increases costs for sponsors and threatens the viability of the trial itself.

Directly supporting patients from prescreening to study endpoint can help minimize delays and safeguard against early termination, but this can be difficult for hard-pressed sites. Join us as we discuss the most common patient support challenges – as described to us by YOU – and how our new Navigator can solve them by giving patients a more personalized clinical trial experience and consistent contact, alleviating the burden on sites, and ensuring a sponsor’s study runs efficiently to help accelerate patient access to life-changing treatments.

We will share our insight into why the ‘human touch’ can elevate your in-study patient engagement to the next level and how this permeates through our Navigator service to benefit patients, sites and sponsors. You will also hear from a sponsor that has benefitted from our expertise: the difficulties they faced, the solutions we implemented and the difference we made. And we will share feedback from clinical trial participants about what they think of our support.

This content was provided by Innovative Trials

Company Details

 Latest Content from  Innovative Trials 

Three predictions for the clinical trial industry in 2022

Kate Shaw, Innovative Trials Founder & CEO, looks ahead to 2022 by listing three predictions for the clinical trial industry in 2022

World Cancer Day – February 2022

World Cancer Day is celebrated around the world in February in February and innovative Trials wants to take this opportunity to raise awareness around cancer

Personalised medicine: driving a need for greater diversity in clinical trials

Kate Shaw, Innovative Trials' Founder & CEO, investigates one of the biggest challenges facing clinical research today.

Cervical Cancer Prevention Month

In this first 2022 blog, the Innovative Trials' Equality & Diversity committee will be looking at raising awareness around Cervical Cancer

Meet Innovative Trials at SCOPE 2022

Stop by Booth 1015 to meet the Innovative Trials' team during SCOPE 2022

Interview with Kate Shaw, Innovative Trials’ Founder/CEO

2021 has been a very busy year for Innovative Trials and Kate Shaw discusses the main highlights.

Diversity in clinical trials: looking back at our 2021 blogs

In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021

Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)

How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch

Six ways to improve diversity in clinical trials

Diversity is becoming increasingly important as a focus of clinical trials. This whitepaper gives six approaches that could be implemented to help make diversity a bigger focus on your clinical...

Men’s Health Awareness Month

In this November blog, Innovative Trials will be looking at the men's health and the Movember movement which aims at raising awareness around men's health